Screener
Mirum Pharmaceuticals, Inc. MIRM Available For Sale Securities Debt Securities Current
Available For Sale Securities Debt Securities Current at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.
The source filing: Mirum Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001759425-26-000045
| Line item | Amortized Cost | Unrealized Gain | Unrealized Loss | Estimated Fair Value |
|---|---|---|---|---|
| Agency bonds | 16,500 | — | (69) | 16,431 |
| Commercial paper | 17,970 | — | — | 17,970 |
| Total cash equivalents and investments | $493,743 | $6 | $(472) | $493,277 |
| Classified as: | ||||
| Cash equivalents | $262,684 | |||
| Short-term investments | 107,563 | |||
| Long-term investments | 123,030 | |||
| Total cash equivalents and investments | $493,277 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Mirum Pharmaceuticals, Inc.'s available for sale securities debt securities current?
- Mirum Pharmaceuticals, Inc. (MIRM) reported available for sale securities debt securities current of $107.56M in Q2 2026.
- How has Mirum Pharmaceuticals, Inc.'s available for sale securities debt securities current changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s available for sale securities debt securities current increased by 40.7% year-over-year, from $76.43M to $107.56M.
- What does available for sale securities debt securities current mean?
- Available For Sale Securities Debt Securities Current
Ask your AI about Mirum Pharmaceuticals, Inc.'s available for sale securities debt securities current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude